Predictive Value of Intratumoral Microvascular Density in Patients with Advanced Non-small Cell Lung Cancer Receiving Chemotherapy Plus Bevacizumab
Authors:
- Cong XueCXCong Xue
- Wei JiangWJWei Jiang
- Hong-Yun ZhaoHZHong-Yun Zhao
- Yan HuangYHYan Huang
- Kristin FeenstraKFKristin Feenstra
- James H. ResauJRJames H. Resau
- Chao-Nan QianCQChao-Nan Qian
- Li ZhangLZLi Zhang
- 1 January 2012
- journal article
- Published by Elsevier in Journal of Thoracic Oncology
- Vol. 7 (1) , 71-75
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Angiogenesis: multiple masks in hepatocellular carcinoma and liver regenerationHepatology International, 2010
- Complexity of tumor vasculature in clear cell renal cell carcinomaCancer, 2009
- Antiangiogenic therapy using bevacizumab in recurrent high-grade glioma: impact on local control and patient survivalJournal of Neurosurgery, 2009
- Inhibition of MAPK Kinase Signaling Pathways Suppressed Renal Cell Carcinoma Growth and Angiogenesis In vivoCancer Research, 2008
- Two Distinct Types of Blood Vessels in Clear Cell Renal Cell Carcinoma Have Contrasting Prognostic ImplicationsClinical Cancer Research, 2007
- Impact of Vascular Endothelial Growth Factor-A Expression, Thrombospondin-2 Expression, and Microvessel Density on the Treatment Effect of Bevacizumab in Metastatic Colorectal CancerJournal of Clinical Oncology, 2006
- Bevacizumab (Avastin), a humanized anti-VEGF monoclonal antibody for cancer therapyBiochemical and Biophysical Research Communications, 2005
- Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawalJournal of Clinical Investigation, 1999
- Mechanisms of angiogenesisNature, 1997
- Platelet Endothelial Cell Adhesion Molecule-1 (PECAM-1): A Potential Prognostic Marker Involved in Leukocyte Infiltration of Renal Cell CarcinomaOncology, 1996